Supreme Court will rule on patent licensing dispute

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Supreme Court will rule on patent licensing dispute

The US Supreme Court agreed on Monday to accept a patent dispute between Boston Scientific and medical devices manufacturer Medtronic

The case, Medtronic v Boston Scientific, concerns patents relating to a device made by Medtronic known as cardiac resynchronization therapy (CRT). The equipment tracks the patient’s heartbeat to ensure both the right and left ventricles contract simultaneously, and administers electric shocks to restore the proper balance if they get out of sync.

The patents are owned by Mirowski Family Ventures, which licensed them exclusively to Natick, Massachusetts-based Boston Scientific.

The companies agreed that Medtronic would license the patents and pay royalties if it produced any new products which used the technology covered by them.

In 2007, Mirowski alleged that new products Medtronic was developing qualified for royalty fees.

Medtronic subsequently sued, seeking a declaratory judgment that it had not infringed the patents, US reissue patents RE38,119 and RE39,897. Medtronic claims that the onus falls on the patent owner to prove infringement.

A Delaware court ruled that Medtronic was not infringing, but the Federal Circuit overturned the decision in September 2012, concluding that the onus was on Medtronic to prove that it hadn’t infringed.

Usually, the burden of proving infringement falls to the patent holder. But the Federal Circuit reversed this approach, deciding instead to shift the burden to Medtronic because the Fridley-based company was a licensee seeking a declaratory judgment of non-infringement.

The Supreme Court will now review whether the Federal Circuit’s decision to shift the burden was correct. Medtronic claims the appellate court’s ruling creates a loophole allowing patent owners a risk-free way to increase the scope of their licenses to cover new products.

Medtronic has so far been represented by Robins Kaplan Miller & Ciresi in the case and Mirowski has been represented by Oblon Spivak McClelland Maier & Neustadt.

more from across site and SHARED ros bottom lb

More from across our site

Lateral hires at Thompson Hine and Pierson Ferdinand said they were inspired by fresh business opportunities and innovative strategies at their new firms
The launch of a new IP insurance product and INTA hiring a former USPTO commissioner were also among the top talking points this week
The firm explains how it secured a $170.6 million verdict against the government in a patent dispute surrounding airport technology, and why the case led to interest from other inventors
Developments of note included the court partially allowing a claim concerning confidentiality clubs and a decision involving technology used in football matches
The firm said adding capability in the French capital completes its coverage of all major patent litigation jurisdictions as it strives for UPC excellence
Marc Fenster explains how keeping the jury focused on the most relevant facts helped secure a $279m win for his client against Samsung
Clients are divided on what externally funded IP firms bring to the table, so those firms must prove why the benefits outweigh the downsides
Rahul Bhartiya, AI coordinator at the EUIPO, discusses the office’s strategy, collaboration with other IP offices, and getting rid of routine tasks
A boom in transactional work and a heightened awareness of IP have helped boost revenue for the rebranded commercial services team
Clemens Heusch, head of global litigation and dispute resolution at Nokia, tells us why open conversations – and respectful challenges – lead to the best results
Gift this article